|
1-O-hexadecyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphocholine
|
K021220-25mg
|
99% |
132196-28-2 |
25mg
|
¥ 22487.0
|
4~8周 |
0 |
科威 |
|
1-O-hexadecyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphocholine
|
K021220-5mg
|
99% |
132196-28-2 |
5mg
|
¥ 5723.0
|
4~8周 |
0 |
科威 |
|
混合甲基萘
|
K019325-100g
|
80% |
1321-94-4 |
100g
|
¥ 845.0
|
現貨 |
0 |
科威 |
|
二乙烯苯(含穩(wěn)定劑)
|
K012320-500ml
|
55% |
1321-74-0 |
500ml
|
¥ 394.0
|
5~7個工作日 |
0 |
科威 |
|
二乙烯苯(含穩(wěn)定劑)
|
K012320-100ml
|
55% |
1321-74-0 |
100ml
|
¥ 102.0
|
現貨 |
0 |
科威 |
|
二乙烯苯(含穩(wěn)定劑)
|
K012319-100ml
|
50% |
1321-74-0 |
100ml
|
¥ 95.0
|
現貨 |
0 |
科威 |
|
二乙烯苯(含穩(wěn)定劑)
|
K012319-500ml
|
50% |
1321-74-0 |
500ml
|
¥ 204.0
|
現貨 |
0 |
科威 |
|
二乙烯苯((含穩(wěn)定劑))
|
K012318-500ml
|
80% |
1321-74-0 |
500ml
|
¥ 248.0
|
現貨 |
0 |
科威 |
|
二乙烯苯((含穩(wěn)定劑))
|
K012318-25ml
|
80% |
1321-74-0 |
25ml
|
¥ 48.0
|
現貨 |
0 |
科威 |
|
二乙烯苯((含穩(wěn)定劑))
|
K012318-100ml
|
80% |
1321-74-0 |
100ml
|
¥ 114.0
|
現貨 |
0 |
科威 |
|
苯扎托品
|
K019216-1g
|
98% |
132-17-2 |
1g
|
¥ 355.0
|
4~8周 |
0 |
科威 |
|
苯扎托品
|
K019216-5g
|
98% |
132-17-2 |
5g
|
¥ 1314.0
|
4~8周 |
0 |
科威 |
|
3,4,5-三氟苯甲醛
|
K010094-5g
|
98% |
132123-54-7 |
5g
|
¥ 210.0
|
現貨 |
0 |
科威 |
|
3,4,5-三氟苯甲醛
|
K010094-1g
|
98% |
132123-54-7 |
1g
|
¥ 81.0
|
現貨 |
0 |
科威 |
|
反-3,4,5-三氟-4''-(4-n-丙基環(huán)己基)聯苯
|
K021219-5g
|
99% |
132123-39-8 |
5g
|
¥ 2687.0
|
4~8周 |
0 |
科威 |
|
反-3,4,5-三氟-4''-(4-n-丙基環(huán)己基)聯苯
|
K021219-1g
|
99% |
132123-39-8 |
1g
|
¥ 764.0
|
4~8周 |
0 |
科威 |
|
7-溴-2-氯-3-乙基喹啉
|
K021218-100mg
|
95% |
132118-52-6 |
100mg
|
¥ 696.0
|
4~8周 |
0 |
科威 |
|
2-特丁氧基乙酸
|
K021217-1g
|
98% |
13211-32-0 |
1g
|
¥ 169.0
|
現貨 |
0 |
科威 |
|
鹽酸羅哌卡因
|
K014284-25g
|
99% |
132112-35-7 |
25g
|
¥ 1201.0
|
現貨 |
0 |
科威 |
|
鹽酸羅哌卡因
|
K014284-5g
|
99% |
132112-35-7 |
5g
|
¥ 400.0
|
現貨 |
0 |
科威 |
|
鹽酸羅哌卡因
|
K014284-1g
|
99% |
132112-35-7 |
1g
|
¥ 150.0
|
現貨 |
0 |
科威 |
|
2,2′-亞甲基雙[(4,s)-4-苯基-2-噁唑啉]
|
K021216-1g
|
97% |
132098-59-0 |
1g
|
¥ 5363.0
|
4~8周 |
0 |
科威 |
|
2,2′-亞甲基雙[(4S)-4-叔丁基-2-噁唑啉]
|
K021215-5g
|
96% |
132098-54-5 |
5g
|
¥ 8063.0
|
4~8周 |
0 |
科威 |
|
2,2′-亞甲基雙[(4S)-4-叔丁基-2-噁唑啉]
|
K021215-250mg
|
96% |
132098-54-5 |
250mg
|
¥ 805.0
|
4~8周 |
0 |
科威 |